The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

Calamba City — As obesity and diabetes cases continue to rise not only in Metro Manila but also in the provinces, international medical experts will gather later this month to share strategies that ...

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in ...

Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that three internationally recognized authorities in endocrinology and diabetes, Prof. Luc Van Gaal, Prof. David ...

Friendly” labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like ...

After a cancer diagnosis, 7 in 10 people now survive five years or more, according to a report from the American Cancer ...

Scripps Research scientists are helping start-up NuVee Inc. in eyeing a clinical trial for Koa, its ’emotionally intelligent ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...